Stock 8622 HUAKANG BIOMEDICAL HOLDINGS COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Huakang Biomedical Holdings Company Limited

Equities

8622

KYG4644W1069

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:06 2024-04-30 am EDT 		5-day change 1st Jan Change
0.098 HKD -5.77% Intraday chart for Huakang Biomedical Holdings Company Limited -1.01% -8.41%
Mar. 28 Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 25 Huakang Biomedical Holdings Company Limited Provides Group Earnings Guidance for the Year Ended 31 December 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Huakang Biomedical Holdings Company Limited Provides Group Earnings Guidance for the Year Ended 31 December 2023
CI
An unknown buyer acquired 15.59% stake in Huakang Biomedical Holdings Company Limited from Ever Charming Inc for HKD 3.2 million.
CI
Huakang Biomedical Holdings Company Limited Announces Change of Address of Head Office, Effect from 18 December 2023
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Huakang Biomedical Holdings Company Limited Appoints Chow Ching Man as Independent Non-Executive Director Member of Audit Committee and Nomination Committee
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Huakang Biomedical Holdings Company Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2021
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
CI
Huakang Biomedical Holdings Company Limited Provides Group Earnings Guidance for the Nine Months Ended September 30, 2021
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Second Quarter Ended June 30, 2021
CI
Huakang Biomedical Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2021
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the First Quarter Ended March 30, 2021
CI
Huakang Biomedical Holdings Company Limited Provides Unaudited Consolidated Earnings Guidance for the Three Months Ended March 31, 2021
CI
Huakang Biomedical Holdings Company Limited Reports Earnings Results for the Full Year Ended December 31, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8622 Stock
  4. News Huakang Biomedical Holdings Company Limited